Betel quid cessation therapy with nicotine and pilocarpine
AssigneeUniversity of Florida Research Foundation, Inc.
InventorsRoger L. Papke, Samuel Leslie Glatman
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions comprising nicotine, or a salt thereof, and pilocarpine, or a salt thereof, useful for reducing the use of betel quid and/or achieving betel quid cessation (e.g., replacement therapy). Also provided herein are methods of using the compositions in reducing the risk of developing or reducing the progression of a disease (e.g., cancer, oral disease, neurological disease, or painful condition). Compositions of the present invention may be administered to a subject with an addiction, e.g., a betel quid addiction, areca nut addiction, and/or nicotine addiction.
Claims15
A composition consisting of nicotine, or a salt thereof, pilocarpine, or a salt thereof, and optionally an acceptable carrier, excipient, or buffer for oral administration.
Dependencies are inferred from the claim text.